Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 12.0% | 12.6% | 6.6% | 10.6% | 12.4% | 23.4% | 19.6% | 25.3% | 14.7% | 7.2% | 3.6% | 2.6% | 12.5% | (9.0%) | 17.2% | 1.2% | (0.1%) | 6.9% | 5.5% | 17.2% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is 8.7%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Bristol-Myers Squibb Company have been 7.7% over the past three years, and 6.7% over the past five years.
As of today, Bristol-Myers Squibb Company's ROIC - WACC is 8.7%, which is lower than industry median of 8.9%. It indicates that Bristol-Myers Squibb Company's ROIC - WACC is Bad.